Florida SB 1158: Motor Vehicle Lights and Signals

Bill Text

1158 
Drug Prices and Coverage 
2026-01-06T04:10:02Z 
Requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; requiring the agency to publish annually prescription drug reference prices; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products; requiring prescription drug manufacturer permitholders to annually report to the agency international drug price data beginning on a specified date; requiring certain health insurers to limit covered prescription drug reimbursement to reference prices, etc. 
Original Filed Version 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 1158 

 By Senator Grall 

 29-01540A-26 20261158__ 
 1 A bill to be entitled 
 2 An act relating to drug prices and coverage; creating 
 3 s. 381.02036, F.S.; requiring the Agency for Health 
 4 Care Administration to contract with an entity to 
 5 designate reference price source countries and analyze 
 6 certain data; defining the term “real gross domestic 
 7 product per capita”; providing duties for the 
 8 contracted entity; requiring the agency to publish 
 9 annually prescription drug reference prices; amending 
 10 s. 465.0244, F.S.; prohibiting pharmacies from 
 11 charging cash-paying customers more than the reference 
 12 prices for prescribed drugs and biological products; 
 13 providing applicability; creating s. 499.044, F.S.; 
 14 providing legislative intent; defining the terms 
 15 “prescription drug” and “drug”; requiring prescription 
 16 drug manufacturer permitholders to annually report to 
 17 the agency international drug price data beginning on 
 18 a specified date; specifying reporting requirements 
 19 and penalties; amending s. 626.8825, F.S.; defining 
 20 terms; requiring that contracts between pharmacy 
 21 benefit managers and pharmacy benefits plans and 
 22 programs prohibit pharmacy benefit managers from 
 23 offering and implementing certain formularies; 
 24 requiring that contracts between pharmacy benefit 
 25 managers and participating pharmacies allow a 
 26 specified option in the administrative appeal 
 27 procedure; amending s. 626.8827, F.S.; prohibiting 
 28 pharmacy benefit managers from engaging in certain 
 29 practices relating to pharmacies and pharmacists; 
 30 creating s. 627.4231, F.S.; defining terms; requiring 
 31 certain health insurers to limit covered prescription 
 32 drug reimbursement to reference prices; requiring that 
 33 savings from such reimbursement limits be used for 
 34 certain purposes; providing documentation, assessment, 
 35 and reporting requirements for such health insurers; 
 36 providing applicability; requiring the Office of 
 37 Insurance Regulation and the agency to submit an 
 38 annual report to the Governor and the Legislature; 
 39 creating s. 627.42398, F.S.; requiring that certain 
 40 health insurance policies limit changes to 
 41 prescription drug formularies under certain 
 42 circumstances; providing applicability; providing 
 43 construction; amending s. 627.6699, F.S.; requiring 
 44 small employer carriers to limit changes to 
 45 prescription drug formularies; amending s. 641.30, 
 46 F.S.; requiring health maintenance organizations to 
 47 comply with requirements on limits on prescription 
 48 drug reimbursement and on the uses of savings from 
 49 such limits; amending s. 641.31, F.S.; prohibiting the 
 50 inclusion of specified provisions in certain health 
 51 maintenance contracts; providing applicability; 
 52 providing construction; requiring the Financial 
 53 Services Commission to adopt certain rules by a 
 54 specified date; providing a declaration of important 
 55 state interest; providing an effective date. 
 56 
 57 Be It Enacted by the Legislature of the State of Florida: 
 58 
 59 Section 1. Section 381.02036, Florida Statutes, is created 
 60 to read: 
 61 381.02036 International drug reference pricing.—The Agency 
 62 for Health Care Administration shall contract with an entity to 
 63 designate reference price source countries and analyze the data 
 64 submitted under s. 499.044 to establish the reference price for 
 65 each prescribed drug. 
 66 (1)(a) The list of reference price source countries must 
 67 include only countries with a real gross domestic product per 
 68 capita of at least 60 percent of the United States gross 
 69 domestic product per capita, using international sales, volume, 
 70 and pricing data for each country. For the purposes of this 
 71 paragraph, the term “real gross domestic product per capita” 
 72 means a country’s most recent estimate based on purchasing power 
 73 parity for that country available in the most recent edition of 
 74 the United States Central Intelligence Agency World Factbook. 
 75 Countries with single-payer health care systems, which include 
 76 whole-market government